Reset Pharma has entered a licensing agreement with Filament for psilocybin drug...
Huadong has entered into an agreement to acquire licence rights for MC2 Therapeu...
In the latest edition of STAT's Health Tech newsletter: Biofourmis turmoil, Alex...
Though still in mouse experiments, a new, precise gene editing trick could lead ...
Stanford’s now ex-president Marc Tessier-Lavigne retracted two studies published...
The patients who took psilocybin experienced reduced depressive symptoms, an eff...
Large clinical trials are now testing amyloid-clearing drugs in people without s...
Layoffs in the U.S. pharmaceutical industry dipped in August, but the total for ...
As pharmaceutical companies bemoan Medicare’s drug negotiations, hospitals and d...
“Waiving out-of-pocket costs for this emergency medication aligns with our commi...
The recent Covid mini-surge shows we need more tools to combat the virus.
“If you neglect miscarriage, you miss that opportunity of really positively affe...
Kuldeep Singh Rajput, a co-founder and CEO of Biofourmis, has quietly stepped do...
Medicaid warned states Wednesday that they could be mistakenly removing children...
"We consider this price reduction to be a big feat,” said Brenda Waning, who hea...
A new suggests that patients treated by female surgeons have lower rates of adve...
